title: Perspective of cardiologists on the continuation or discontinuation of antiplatelet therapy before dental treatment: a questionnaire-based study.
abstract: Antiplatelet and anticoagulant agents have been extensively researched and developed as potential therapies in the prevention and management of arterial and venous thrombi. These medications are associated with an increase in bleeding time and risk of intraoperative and postoperative hemorrhage in the dental office. There is some controversy regarding whether these agents should be temporarily discontinued before dental procedures. In order to gain insight into this controversy, a survey of 50 cardiologists was conducted regarding suggested guidelines for dentists in the management of patients who are taking anticoagulant medication.
authors.forename: Ruchi
authors.initials: R
authors.lastname: Banthia
authors.forename: Pallavi
authors.initials: P
authors.lastname: Singh
authors.forename: Priyank
authors.initials: P
authors.lastname: Banthia
authors.forename: Rajbhan
authors.initials: R
authors.lastname: Singh
authors.forename: Santosh
authors.initials: S
authors.lastname: Gupta
authors.forename: Sapna
authors.initials: S
authors.lastname: Raje
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage*; D003752:Dental Health Services; D004334:Drug Administration Schedule; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D011795:Surveys and Questionnaires
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors
keywords: antiplatelet therapy; bleeding risk; dental treatment; thromboembolic events